3 - Opioids Flashcards
What are Mu1 receptors responsible for:
Analgesia
What are Mu2 receptors responsible for:
Respiratory depression, miosis, reduced gastric motility, sedation, euphoria, pruritis, urinary retention, PHYSICAL DEPENDENCE
What are Kappa receptors responsible for?
Contribute to analgesic properties (but Mu1 is responsible for most of the analgesia)
What is the Delta receptor responsible for?
Located in the periphery and selective for enkephalins
Which is more hydrophilic - morphine or fentanyl?
Morphine
Which is more lipophilic - morphine or fentanyl?
Fentanyl
What causes tolerance?
Down-regulation of opioid receptors
What is opioid-induced hyperalgia?
Increased pain or pain sensitivity without a change in medical condition
Desensitization is the result of:
Down-regulation
Which opioid is associated with the greatest histamine release and thus “itching” sensation?
Morphine
Morphine - MOA?
High affinity for Mu1 and Mu2
Weak affinity for Delta/Kappa
Morphine - pharmacokinetics:
Significant first pass effect if oral
Least lipophilic - only a small amount crosses BBB -> less euphoria than fentanyl or heroin
Will cross placenta
Heroin is __ times more potent than morphine
6
Presence of morphine in urine could indicate exposure to:
Morphine
Heroin
Codeine
Morphine - AE’s?
Increases ICP (caution in head injury)
Respiratory depression
N/V
Pruritus
HOTN
Hydromorphone (Dilaudid) - MOA:
Mu receptor agonist
Metabolite of morphine
More lipophilic than morphine
Hydromorphone (Dilaudid) - note on extended release form:
Requires provider training q 2 yrs - Risk Evaluation and Mitigation Strategy (REMS) drug
Hydrocodone ER (Zohydro ER) - MOA:
Less binding affinity than morphine
Metabolizes to hydromorphone
Oxycodone (OxyContin) - MOA:
Mu receptor agonist - low binding affinity
Metabolizes to noroxycodone and oxymorphone (active metabolites)
Oxymorphone (Numorphan) - MOA:
Semi-synthetic Mu receptor agonist
Greater analgesic profile than morphine
Codeine - MOA:
PRODRUG (no analgesic activity)
Metabolized to morphine
Codeine - clinical use:
Mild to moderate pain
Antitussive
Codeine - box warning:
Death delated to ultra-rapid metabolism of codeine to morphine
Not recommended for peds <12
What is the CYP enzyme responsible for converting codeine to morphine?
CYP2D6
If Codeine is single ingredient, what schedule?
II
If codeine combined with another analgesic (i.e. APAP), what schedule?
III
If Codeine combined with Guaifenesin (cough medicine), what schedule?
V
Buprenorphine (Buprenex) C-III - MOA:
Mixed agonist/antagonist
Partial Mu agonist and Kappa ANTagonist
Buprenorphine (Buprenex) - clinical use?
Opioid detoxification
As effective as methadone
Resistant to naloxone d/t long duration of action
Butorphanol (Stadol) C-IV - MOA?
Partial Mu and Kappa agonist
Butorphanol (Stadol) C-IV - clinical use:
Pain management
Pain during labor (if epidural is not possible)
Butorphanol (Stadol) C-IV - AE’s?
Can produce unwanted dysphoria
Nalbuphine (Nubain) - MOA:
Not controlled
Partial Mu antagonist
Strong Kappa agonist
Nalbuphine (Nubain) - clinical use:
Sedation with minimal respiratory depression
Used to reverse ventilatory depression in opioid overdose WHILE MAINTAINING some alalgesia
Think “Nubain” is the kinder Narcan
Meperidine (Demerol) C-II - MOA:
Strong Mu and Kappa agonist
Anticholinergic effects
Meperidine (Demerol) C-II - clinical use:
ACUTE DOSING ONLY
Relief of moderate to severe pain
SHIVERING AND RIGORS
USE NOT GENERALLY RECOMMENDED
Meperidine (Demerol) C-II - CI’s?
Renal impairment
MAOI’s
Hepatic impairment
Elderly (caution)
Meperidine (Demerol) C-II - AE’s?
Anticholinergic effects (can cause tachycardia and mydriasis)
HOTN, delirium, seizures
Severe withdrawal
GENERALLY - AVOID THIS DRUG
Fentanyl C-II - MOA:
Mu receptor agonist
Synthetic
75 to 125 time more potent than morphine
More lipophilic (easily crosses BBB leading to more euphoria)
Rapid onset/shorter duration than morphine
Fentanyl - pharmacokinetics:
Renal excretion
Easy distribution in tissues due to high lipohilicity
Fentanyl - clinical use?
Moderate to severe pain (acute)
Moderate to severe pain (chronic)(patches)
Fentanyl - transdermal onset of action:
12 to 24 hours
What is the TIRF REMS program?
Transmucosal Immediate Release Fentanyl Risk Evaluation and Mitigation Strategy
Mitigate the misuse, addiction, overdose, and serious complications due to medication errors with the use of TIRF medicines
Which Fentanyl derivative has the fastest peak effect, duration and elimination?
Remifentanil (think “r” revved up)
What do Alfentanil, Sufentanil, and Remifentanil all have in common?
They don’t accumulate when infused
Methadone - MOA:
Potent agonist of Mu, Kappa, Delta
Antagonist of NMDA receptor
Inhibits serotonin and norepi reuptake
Methadone - clinical use:
Chronic pain syndrome (CA, non-CA, neuropathic)
Detoxification of opioid addiction
Methadone half-life?
Unpredictable - 8 to 59 hours
Difficult to titrate
Analgesia duration is SHORTER than t1/2, toxicity d/t accumulation can occur
Methadone - cardiac AE’s?
Arrhythmias can occur - prolonged QT interval
Pentazocine (Talwin) C-IV - MOA:
Partial Mu agonist
Full kappa agonist
Pentazocine (Talwin) C-IV - clinical use:
Moderate to severe pain
Labor when epidural is not possible
Pentazocine (Talwin) C-IV - AE’s:
HTN Hallucinations Dysphoria Dizziness Tachycardia
Tramadol (Utlram) C-IV: MOA:
Partial Mu receptor agonist
Serotonin and norepinephrine reuptake inhibitor
Tramadol (Ultram) - metabolism:
Majority of therapeutic activity depends on metabolism
Ultra-rapid metabolizers -> significant respiratory depression
Tramadol (Ultram) C-IV- AE’s:
SEROTONIN SYNDROME
Seizures reported at recommended doses
Tapentadol (Nucynta) C-II - MOA:
Chemically similar to tramadol
Mu agonist, norepi reuptake inhibitor
Tapentadol (Nucynta) C-II - clinical use?
Diabetic peripheral neuropathy (ONLY OPIOID WITH THIS INDICATION)
What is the only indication for oral Naloxone?
Opioid-induced constipation
Naltrexone - MOA:
Mu receptor competitive antagonist
Competes but does not displace opioids
Naltrexone - clinical use:
Longer duration of action (10 hrs)
Tx of ETOH and opioid dependence
Naltrexone can be combined with ___ for weight management:
Bupropion
Nalaxone (Narcan) - MOA:
Competitive antagonist of Mu receptors - displaces opioids
Nalaxone (Narcan) - clinical use:
Reversal of opiate overdose
Naloxone can be given every ___ to ___ minutes:
2 to 5
When tapering off opioids, what percentage deduction in amount of drug (for non-addicted patients):
20 to 50 percent (of original dose) per week